Microbicides are products that are designed to be applied to vaginal or rectal mucosa with the intent of preventing or at least significantly reducing the acquisition of sexually transmitted infections including Human Immunodeficiency Virus (HIV). There is increasing epidemiologic evidence that rectal intercourse has the highest risk of HIV acquisition, perhaps 10 to 20 times more risk than unprotected vaginal intercourse, and that this risky behavior is increasing among women and men. Given the prevalence of this high-risk behavior it is important to develop microbicide gels optimized for rectal administration.

Agency
National Institute of Health (NIH)
Type
NIH Inter-Agency Agreements (Y01)
Project #
AAI12043000-0-0-1
Application #
8932245
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2014
Total Cost
Indirect Cost
City
State
Country
Zip Code